Skip to content
Clinical Trials – home
Universitair Ziekenhuis Gent
Sponsor

Universitair Ziekenhuis Gent

Belgium Corneel Heymanslaan 10, 9000 Gent, Belgium

About the sponsor

Universitair Ziekenhuis Gent supports research in oncology with a strong focus on imaging-based assessment and treatment selection across several malignancies, including metastatic non-small-cell lung cancer, hepatocellular carcinoma, thyroid carcinoma, head and neck squamous cell carcinoma, glioblastoma, breast cancer, and oligorecurrent prostate cancer.

  • Positron emission tomography and tumor staging
  • Prostate-specific membrane antigen-directed imaging
  • Radiotherapy and systemic treatment strategies
  • Immunotherapy in advanced solid tumors

Its research activity also includes imaging-guided evaluation of metastatic and recurrent disease, with interest in peritoneal metastases and response assessment in advanced cancer settings.

About Specializations

Universitair Ziekenhuis Gent runs clinical trials in conditions such as Infertility, Haematological malignancy, Abdominal infection, Pneumonia bacterial, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

19 clinical trials

Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Universitair Ziekenhuis Gent
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Cefotaxime
  • Sponsor:Universitair Ziekenhuis Gent
Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Gozetotide Alf-18
  • Sponsor:Universitair Ziekenhuis Gent
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Guselkumab
  • Sponsor:Universitair Ziekenhuis Gent
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Amoxicillin Sodium
  • Sponsor:Universitair Ziekenhuis Gent
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Melphalan
  • Sponsor:Universitair Ziekenhuis Gent

Infertility

Recruiting
Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:Corifollitropin Alfa
  • Sponsor:Universitair Ziekenhuis Gent
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Colchicine
  • Sponsor:Az St-Jan Brugge-Oostende A.V.
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:Corifollitropin Alfa
  • Sponsor:Universitair Ziekenhuis Gent
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Technetium (99Mtc) Certolizumab Pegol
  • Sponsor:Universitair Ziekenhuis Gent
Registered drug
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Remifentanil
  • Sponsor:Universitair Ziekenhuis Gent

Thyroid cancer+1

Recruiting
Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Gozetotide Alf-18
  • Sponsor:Universitair Ziekenhuis Gent

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).